AlphaYou
Overview
Key stats
Fundamentals Sep 10- Open
- $12.50
- 52-wk high
- $13.90
- High
- $12.61
- 52-wk low
- $7.36
- Low
- $11.99
- Prev close
- $12.09
- Mkt cap
- $1.11B
- Volume
- 2.21M
- Beta
- 0.43
- P/S
- 14.4x
- P/B
- 24.3x
- Profit margin
- +0.0%
- Op margin
- -349.8%
- ROE
- -167.7%
What do analysts expect?
Analyst target and ratings are on paid plans
See the 12-month consensus target and the buy/hold/sell rating split.
Unlock the full resultsSmart money
8 funds hold a position and insiders have been net selling.
What insiders are doing
Earnings
Earnings came in 13.5% above what analysts expected.
Earnings per share
-$0.89 expected
Reports Nov 3, 2026, in 54 days
EPS expected
-$0.99 to -$0.70
Revenue expected
13 analysts
Last 30 days
Analysts raising estimates
Estimate drift
Change in 30 days
Financials
What it sold, what it cost, what was left.
| USD | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|
| What came in | ||||
| Revenue | $20.8M | $17.3M | $18.3M | $20.9M |
| Cost of what it sold | $3.2M | $460.0K | $617.0K | $243.0K |
| Gross profit | $17.5M | $17.3M | $17.6M | $20.6M |
| What it spent | ||||
| Research and development | $67.9M | $64.4M | $65.3M | $61.9M |
| Sales and admin | $32.8M | $39.1M | $31.6M | $31.8M |
| Other operating costs | -$3.2M | — | — | — |
| Total operating expenses | $97.5M | $103.6M | $96.5M | $93.6M |
| What was left | ||||
| Operating profit | -$80.0M | -$86.3M | -$78.8M | -$73.0M |
| Interest on debt | $393.0K | $346.0K | $336.0K | $345.0K |
| Profit before tax | -$74.1M | -$80.9M | -$73.3M | -$68.3M |
| Tax | — | $71.0K | $8.0K | $5.0K |
| Net profit | -$74.1M | -$81.0M | -$73.3M | -$68.3M |
| EBITDA | -$74.0M | -$80.2M | -$72.6M | -$65.6M |
Technicals
Price structure
This stock is in a strong uptrend.
Trend
Strong uptrend
80 / 100
RSI 14
20D volatility
52-week range
20D support
20D resistance
Returns
Price vs moving averages
Volume pace
News
What the news says
Coverage is bullish
Tone of tracked coverage
Price-Driven Insight from (KURA) for Rule-Based Strategy
NeutralSep 3Kura Oncology (KURA) Stock Looks Fully Priced After Its 56% Run
Leans bearishSep 3Kura Oncology (KURA) Upgraded to Buy: What Does It Mean for the Stock?
BullishAug 31The $1.24 Billion Reason Why Kura Oncology Stock Is Up Today
NeutralAug 25Kura Oncology Shares Rise After CEO Purchases 100,000 Shares
BullishAug 25Kura Oncology Shares Surge 9% Following CEO’s $2.35 Million Purchase Over Eight Days
BullishAug 25Kura Oncology Shares Jump After CEO Buys $1.24 Million of Stock
BullishAug 25Kura Oncology CCO Brian Powl sells $51,663 in shares
NeutralAug 25
Macro
11 macro signals shaping KURA right now
Unlock sector rotation, regime shifts, and macro event windows tied to this stock.
Unlock the full results